A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines
Clinical trial NCT05496335 · COMPLETED
Trial details
- NCT number
- NCT05496335
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-30
- Primary completion
- 2023-05-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.